Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.
Jun 17, 2019
0
0
In May, the Food and Drug Administration issued much-anticipated guidance that could revolutionize the pricing of some of the most expensive drugs on the market in the U.S. and, possibly, globally.
Jun 4, 2019
0
0
After reviewing tens of millions of insurance claims for the country's 49 most popular brand-name prescription drugs, a team from Scripps Research Translational Institute found that net prices rose by a median of 76 percent ...
May 31, 2019
4
99
TV pitches for prescription drugs will soon include the price, giving consumers more information upfront as they make medication choices at a time when new drugs can carry anxiety-inducing prices.
May 8, 2019
0
1
(HealthDay)—Two position statements developed in relation to drug pricing and step therapy have been issued by the American College of Rheumatology (ACR).
Apr 15, 2019
0
1
(HealthDay)—The same services are more expensive when performed in outpatient versus office settings, according to a blog post from the Health Care Cost Institute.
Apr 10, 2019
0
1
The nation's largest health insurer is expanding a program that passes rebates from drugmakers directly to the people that use their medications.
Mar 12, 2019
0
0
Paying for cancer drugs based on how well they work in practice could help patients get new treatments faster, according to a Cancer Research UK report published today.
Feb 21, 2019
0
0
(HealthDay)—In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.
Feb 13, 2019
0
1
Medicare patients with multiple sclerosis face skyrocketing out-of-pocket costs for therapies due to complicated insurance rules that force them to pick up an increasing share of the cost, according to new research.
Feb 4, 2019
0
15
